title: Human papillomaviruses: genetic basis of carcinogenicity.
abstract: Persistent infection by specific oncogenic human papillomaviruses (HPVs) is established as the necessary cause of cervix cancer. DNA sequence differences between HPV genomes determine whether an HPV has the potential to cause cancer. Of the more than 100 HPV genotypes characterized at the genetic level, at least 15 are associated, to varying degrees, with cervical cancer. Classification based on nucleotide similarity places nearly all HPVs that infect the cervicovaginal area within the alpha-PV genus. Within this genus, phylogenetic trees inferred from the entire viral genome cluster all cancer-causing types together, suggesting the existence of a common ancestor for the oncogenic HPVs. However, in separate trees built from the early open reading frames (ORFs; i.e. E1, E2, E6, E7) or the late ORFs (i.e. L1, L2), the carcinogenic potential sorts with the early region of the genome, but not the late region. Thus, genetic differences within the early region specify the pathogenic potential of alpha-HPV infections. Since the HPV genomes are monophyletic and sites are highly correlated across the genome, diagnosis of oncogenic types and non-oncogenic types can be accomplished using any region across the genome. Here we review our current understanding of the evolutionary history of the oncogenic HPVs, in particular, we focus on the importance of viral genome heterogeneity and discuss the genetic basis for the oncogenic phenotype in some but not all alpha-PVs.
authors.affiliation: Department of Pediatrics, Division of Genetics, Albert Einstein Cancer Center, New York, NY 10461, USA. burk@aecom.yu.edu
authors.forename: Robert D
authors.initials: RD
authors.lastname: Burk
authors.forename: Zigui
authors.initials: Z
authors.lastname: Chen
authors.forename: Koenraad
authors.initials: K
authors.lastname: Van Doorslaer
mesh_terms: D019143:Evolution, Molecular; D005260:Female; D014644:Genetic Variation; D016679:Genome, Viral; D052162:Human papillomavirus 16 / Q000235:genetics; D006801:Humans; D008957:Models, Genetic; D027383:Papillomaviridae / Q000235:genetics*; D030361:Papillomavirus Infections / Q000150:complications / Q000235:genetics; D010641:Phenotype; D010802:Phylogeny; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000821:virology
references.citation: Sex Transm Dis. 2007 Nov;34(11):849-55
references.pmid: 17621246
references.citation: Am J Pathol. 2000 Oct;157(4):1055-62
references.pmid: 11021808
references.citation: Cell. 1993 Nov 5;75(3):495-505
references.pmid: 8221889
references.citation: Nature. 1998 Nov 5;396(6706):84-8
references.pmid: 9817205
references.citation: Proc Natl Acad Sci U S A. 1993 May 1;90(9):3988-92
references.pmid: 8387205
references.citation: Hosp Pract (1995). 1999 Nov 15;34(12):103-11; quiz 112
references.pmid: 10616548
references.citation: J Virol. 2009 Feb;83(3):1443-55
references.pmid: 19036820
references.citation: Cell. 1990 Dec 21;63(6):1129-36
references.pmid: 2175676
references.citation: J Virol. 1993 Nov;67(11):6413-23
references.pmid: 8411343
references.citation: Int J Cancer. 2007 Jul 1;121(1):193-8
references.pmid: 17351898
references.citation: J Virol. 1982 Oct;44(1):393-400
references.pmid: 6292500
references.citation: Curr Top Microbiol Immunol. 1977;78:1-30
references.pmid: 202434
references.citation: J Virol. 1993 Nov;67(11):6424-31
references.pmid: 8411344
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/1-10
references.pmid: 16949995
references.citation: Virology. 2005 Sep 15;340(1):95-104
references.pmid: 16039686
references.citation: J Virol. 1996 May;70(5):3127-36
references.pmid: 8627792
references.citation: Trends Microbiol. 2005 Nov;13(11):514-21
references.pmid: 16181783
references.citation: Eur J Biochem. 1986 Feb 3;154(3):665-72
references.pmid: 2419131
references.citation: J Infect Dis. 2005 Jun 1;191(11):1796-807
references.pmid: 15871111
references.citation: Virology. 1991 Oct;184(2):492-503
references.pmid: 1653484
references.citation: J Natl Cancer Inst Monogr. 2003;(31):20-8
references.pmid: 12807941
references.citation: Lancet. 2007 Sep 8;370(9590):890-907
references.pmid: 17826171
references.citation: J Virol. 1986 Feb;57(2):572-7
references.pmid: 3003388
references.citation: J Med Virol. 2002 Nov;68(3):417-23
references.pmid: 12226831
references.citation: Lancet. 2001 Jun 9;357(9271):1831-6
references.pmid: 11410191
references.citation: J Virol. 2005 Nov;79(21):13630-40
references.pmid: 16227283
references.citation: Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11612-6
references.pmid: 9326658
references.citation: Virology. 2005 Jun 20;337(1):76-84
references.pmid: 15914222
references.citation: N Engl J Med. 1998 Feb 12;338(7):423-8
references.pmid: 9459645
references.citation: Virology. 2004 Jun 20;324(1):17-27
references.pmid: 15183049
references.citation: J Clin Microbiol. 1995 Jul;33(7):1746-54
references.pmid: 7665641
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
references.pmid: 16949997
references.citation: J Virol. 2001 May;75(9):4467-72
references.pmid: 11287602
references.citation: N Engl J Med. 2003 Feb 6;348(6):518-27
references.pmid: 12571259
references.citation: J Virol. 1989 Oct;63(10):4417-21
references.pmid: 2476573
references.citation: Science. 1989 Feb 17;243(4893):934-7
references.pmid: 2537532
references.citation: Am J Obstet Gynecol. 2003 Mar;188(3):657-63
references.pmid: 12634637
references.citation: EMBO J. 1984 May;3(5):1151-7
references.pmid: 6329740
references.citation: J Virol. 2005 Jun;79(11):7014-23
references.pmid: 15890941
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1262-7
references.pmid: 16835321
references.citation: J Mol Evol. 2002 Oct;55(4):491-9
references.pmid: 12355268
references.citation: Virology. 1997 Dec 22;239(2):296-302
references.pmid: 9434721
references.citation: J Virol. 2005 May;79(10):6565-9
references.pmid: 15858044
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: J Gen Virol. 2005 May;86(Pt 5):1307-1313
references.pmid: 15831941
references.citation: Oncogene. 1992 Jan;7(1):27-32
references.pmid: 1311063
references.citation: J Virol. 2005 Dec;79(24):15503-10
references.pmid: 16306621
references.citation: Int J Cancer. 2007 Aug 1;121(3):621-32
references.pmid: 17405118
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9557-62
references.pmid: 10449731
references.citation: Proc Natl Acad Sci U S A. 1983 Jun;80(12):3812-5
references.pmid: 6304740
references.citation: EMBO J. 1987 Jun;6(6):1741-6
references.pmid: 3038534
references.citation: Vaccine. 2006 Aug 31;24 Suppl 3:S3/42-51
references.pmid: 16950017
references.citation: Sex Transm Dis. 2007 Jul;34(7):494-502
references.pmid: 17237737
references.citation: Dis Markers. 2007;23(4):213-27
references.pmid: 17627057
references.citation: Virology. 2004 Feb 20;319(2):315-23
references.pmid: 14980491